VP Clinical Development, Glomerular Diseases and Transplant Indications, WCH

Overview

The Vice President of Clinical Development, West Coast Hub (WCH) has a key organizational role, accountable for the clinical strategy and execution of a growing therapeutic-area portfolio in immune mediated diseases, including developing novel targeted therapies for glomerular diseases and transplantation. This leader is responsible for shaping the disease area strategy in close collaboration with Biogen Research, Development, and Commercial leaders and advancing multiple high-priority development programs from IND to registrational studies as well as life-cycle management. This role leads direct and matrixed teams of Medical Directors and Clinical Scientists and / or Clinical Development staff to deliver best-in-class clinical development projects in a mission-driven, science-first environment.

This position is a hybrid-based role in South San Francisco, CA. Consideration may be given to individuals able to commute to CA regularly from US-Remote locations.

MAIN RESPONSIBILITIES

Responsibilities

• Recruit, lead, and develop a high-performing team of Medical Directors and Clinical Scientists that focuses on bringing important therapies to patients, ensuring scientific rigor, mentorship, and opportunities for growth within the enterprise.
• Develop integrated immune mediated disease area strategies in partnership with Research leadership that encompass both translational and clinical insights and provide clinical development oversight of WCH clinical portfolio.
• Create and own the clinical portfolio strategy for glomerular and transplant indications, providing clinical guidance for IND-enabling activities and early clinical experimentation.
• Serve as the medical and strategic leader for assigned programs, leveraging deep expertise in immunology, nephrology, and transplantation.
• Lead and oversee the execution of the glomerular and transplant programs through First-in-Human, Proof of Biology, pivotal, global registrational filings, and life-cycle expansion, with accountability for timelines, risk mitigation, and deliverables, including protocol development, study monitoring, data review, and analysis.
• Collaborate closely with Research counterparts to ensure smooth program transition from discovery to development and optimize the alignment of biomarker strategies and patient selection.
• Work cross-functionally with Clinical Operations, Biometrics, Regulatory, Commercial, and Medical Affairs teams to ensure seamless program execution.
• Partner with External Innovation and Business Development to identify, evaluate, and integrate external clinical-stage assets that complement the internal pipeline.
• Represent the disease area and development programs to internal governance, including Executive Leadership, Board of Directors, and Portfolio Review Committees.
• Actively participate in R&D leadership initiatives and strategic planning to shape the future direction of the company's development portfolio.
• Serve as a matrix leader on cross-functional development teams; support and guide clinical study designs, protocol development, data interpretation, and regulatory interactions.
• Maintain relationships with key opinion leaders, academic institutions, and regulatory bodies investigators in nephrology, transplant medicine, and immunology. Represent Biogen in external forums and scientific partnerships in nephrology and transplantation.

Qualifications

The ideal candidate will have the following mix of professional and personal characteristics :

Professional Qualifications

Personal Characteristics

Additional Information

The base compensation range for this role is : $335,000.00-$486,000.00

Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.

Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.

In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees' and their families physical, financial, emotional, and social well-being; including, but not limited to :

Why Biogen?

We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.

At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.

All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.

#J-18808-Ljbffr